Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Disease Progression and HD[original query] |
|---|
| CAG mutation effect on rate of progression in Huntington's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002 Sep 23 Suppl 2 (): S107-8. Squitieri F, Cannella M, Simonelli |
| Are cognitive changes progressive in prediagnostic HD? Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2007 Dec 20 (4): 212-8. Stout Julie C, Weaver Marjorie, Solomon Andrea C, Queller Sarah, Hui Siu, Johnson Shannon A, Gray Jacqueline, Beristain Xabier, Wojcieszek Joanne, Foroud Tatia |
| Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. Journal of neurology 2009 Feb 256 (2): 203-12. Henley Susie M D, Wild Edward J, Hobbs Nicola Z, Scahill Rachael I, Ridgway Gerard R, Macmanus David G, Barker Roger A, Fox Nick C, Tabrizi Sarah |
| Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma. Gene 2011 Dec 489 (2): 98-102. Gharib Amal F, Karam Rehab A, Pasha Heba F, Radwan Mohamed I, Elsawy Wael |
| CNR1 variation is associated with the age at onset in Huntington disease. European journal of medical genetics 2013 Aug 56 (8): 416-9. Kloster Eugen, Saft Carsten, Epplen Jörg T, Arning Laris |
| Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease. Journal of neurochemistry 2016 Jun . Rodrigues Filipe Brogueira, Byrne Lauren, McColgan Peter, Robertson Nicola, Tabrizi Sarah J, Leavitt Blair R, Zetterberg Henrik, Wild Edward |
| Body weight is a robust predictor of clinical progression in Huntington disease. Annals of neurology 2017 Aug . van der Burg Jorien M M, Gardiner Sarah L, Ludolph Albert C, Landwehrmeyer G Bernhard, Roos Raymund A C, Aziz N Ahm |
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
The Lancet. Neurology 2017 Jun . Moss Davina J Hensman, Pardiñas Antonio F, Langbehn Douglas, Lo Kitty, Leavitt Blair R, Roos Raymund, Durr Alexandra, Mead Simon, , , Holmans Peter, Jones Lesley, Tabrizi Sarah |
| Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis. The Lancet. Neurology 2018 9 17 (11): 986-993. Fusilli Caterina, Migliore Simone, Mazza Tommaso, Consoli Federica, De Luca Alessandro, Barbagallo Gaetano, Ciammola Andrea, Gatto Emilia Mabel, Cesarini Martin, Etcheverry Jose Luis, Parisi Virginia, Al-Oraimi Musallam, Al-Harrasi Salma, Al-Salmi Qasem, Marano Massimo, Vonsattel Jean-Paul Gerard, Sabatini Umberto, Landwehrmeyer Georg Bernhard, Squitieri Ferdinan |
| Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington's Disease. Frontiers in neurology 2018 4 9 190. Liu Jingyu, Ciarochi Jennifer, Calhoun Vince D, Paulsen Jane S, Bockholt H Jeremy, Johnson Hans J, Long Jeffrey D, Lin Dongdong, Espinoza Flor A, Misiura Maria B, Caprihan Arvind, Turner Jessica A, |
| Neurocardiovascular pathology in pre-manifest and early-stage Huntington's disease. European journal of neurology 2018 3 25 (7): 956-962. Bellosta Diago E, Pérez-Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez-Horta S, Kulisevsky J, López Del Val |
| Clinical and genetic characteristics of late-onset Huntington's disease. Parkinsonism & related disorders 2018 12 61 101-105. Oosterloo Mayke, Bijlsma Emilia K, van Kuijk Sander Mj, Minkels Floor, de Die-Smulders Christine |
| Molecular Imaging in Huntington's Disease. International review of neurobiology 2018 11 142 289-333. Wilson Heather, Politis Mari |
| Clinical manifestations of homozygote allele carriers in Huntington disease. Neurology 2019 3 92 (18): e2101-e2108. Cubo Esther, Martinez-Horta Saul-Indra, Santalo Frederic Sampedro, Descalls Asunción Martínez, Calvo Sara, Gil-Polo Cecilia, Muñoz Ignacio, Llano Katia, Mariscal Natividad, Diaz Dolores, Gutierrez Aranzazu, Aguado Laura, Ramos-Arroyo María A, |
| Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease. Movement disorders : official journal of the Movement Disorder Society 2019 Nov . Vuono Romina, Kouli Antonina, Legault Emilie M, Chagnon Lauriane, Allinson Kieren S, La Spada Alberto, , Biunno Ida, Barker Roger A, Drouin-Ouellet Janel |
| Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease. Science translational medicine 2020 Dec 12 (574): . Rodrigues Filipe B, Byrne Lauren M, Tortelli Rosanna, Johnson Eileanoir B, Wijeratne Peter A, Arridge Marzena, De Vita Enrico, Ghazaleh Naghmeh, Houghton Richard, Furby Hannah, Alexander Daniel C, Tabrizi Sarah J, Schobel Scott, Scahill Rachael I, Heslegrave Amanda, Zetterberg Henrik, Wild Edward |
| Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization Study. Neurology. Genetics 2021 7 7 (4): e603. van der Burg Jorien M M, Weydt Patrick, Landwehrmeyer Georg Bernhard, Aziz N Ahm |
| Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients. Parkinsonism & related disorders 2022 5 99 23-29. Hellem Marie N N, Cheong Rachel Y, Tonetto Simone, Vinther-Jensen Tua, Hendel Rebecca K, Larsen Ida U, Nielsen Troels T, Hjermind Lena E, Vogel Asmus, Budtz-Jørgensen Esben, Petersén Åsa, Nielsen Jørgen |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivoH-MRS studies. Neurobiology of disease 2024 6 199 106574. Yinghua Jing, Imis Dogan, Kathrin Reetz, Sandro Romanzet |
| Cerebrospinal fluid glial fibrillary acidic protein, in contrast to amyloid beta protein, is associated with disease symptoms in Huntington's disease. Journal of the neurological sciences 2024 4 459 122979. Sara Korpela, Jimmy Sundblom, Henrik Zetterberg, Radu Constantinescu, Per Svenningsson, Martin Paucar, Valter Nieme |
- Page last reviewed:Feb 1, 2024
- Content source: